The AHA today expressed support for the Opioid Workforce Treatment Act of 2018 (H.R. 5818/S. 2843), bipartisan, bicameral legislation that would reduce the shortage of opioid treatment providers by increasing the number of Medicare-funded residency slots in hospitals with programs focused on substance use disorder treatment. A recent report from the National Academies of Sciences, Engineering and Medicine highlighted the dearth of clinicians with specialized training in Medication Assisted Treatment, and the Substance Abuse and Mental Health Services Administration has estimated that only 10% of the 22 million Americans with a SUD receive treatment. “Your legislation would address these shortages by providing 1,000 additional Medicare-funded residency positions in approved residency programs in addiction medicine, addiction psychiatry or pain management,” AHA said in letters of support to the bills’ sponsors. “These new slots would constitute a major step toward increasing access to SUD treatment for communities in need.”

Related News Articles

Headline
Thirteen states yesterday filed a lawsuit challenging a Department of Homeland Security final rule limiting the ability of legal immigrants to adjust or extend…
Headline
The U.S. Court of Appeals for the District of Columbia Circuit reversed the voiding of a rule that included Medicare and private insurance payments when…
Headline
The Centers for Disease Control and Prevention has released the first in a new series of free online training courses to help health care organizations prevent…
Headline
The AHA today urged the Department of Health and Human Services not to finalize certain proposed revisions to a 2016 final rule implementing the Affordable…
Headline
The AHA today proposed additional actions that the Centers for Medicare…
Chairperson's File
Often quietly and out of the public eye, the vital work of advancing health in America happens on many fronts.